Thermo Fisher Scientific Analytical Instruments — Segment assets decreased by 0.6% to $3.17B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.7%, from $2.94B to $3.17B.
An increase suggests capital expansion or investment in segment capacity, while a decrease may indicate asset divestiture or improved capital efficiency.
This metric represents the total economic resources controlled by the Analytical Instruments operating segment. It encom...
Comparable to segment-specific asset bases reported by diversified life science and industrial technology peers.
tmo_segment_analytical_instruments_segment_assets| Q4 '23 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.73B | $2.91B | $2.94B | $3.19B | $3.17B |
| QoQ Change | — | +6.6% | +1.3% | +8.3% | -0.6% |
| YoY Change | — | — | +8.0% | +9.8% | +7.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.